[Noradrenergic hypothesis in anorexia nervosa: prospective study using beta-stimulant therapy].
We assumed for this study that beta-stimulants could efficient for the treatment of anorexia nervosa not with direct action upon the center of hunger or upon the secretion of insulin but by stimulating the norepinephrine way which is characterized by a function hypotrophy as it is the case in some affective disorder. This experiment was homogenously performed with seven patients. It then presents an encouraging prospective value.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000420:Albuterol / Q000031:analogs & derivatives*; D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000503:physiopathology; D001921:Brain / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D009434:Neural Pathways / Q000503:physiopathology; D009638:Norepinephrine / Q000502:physiology*; D011446:Prospective Studies
D000318:Adrenergic beta-Agonists; C071321:flerobuterol; D000420:Albuterol; D009638:Norepinephrine
Hypothèse noradrénergique dans l'anorexie mentale: étude prospective par un traitement aux bêta-stimulants.